We could not find any results for:
Make sure your spelling is correct or try broadening your search.
- Revenues down 27% due to the discontinuation of services for the SeqOIA platform. Adjusted for this base effect, growth stood at 5% over the period. - Cash position of 1,895 k€ at December 31...
Croissance des activités réalisées aux laboratoires d’Évry Plan de restructuration et de réduction des coûts lié à l’arrêt des prestations pour le GCS SeqOIA en février Résilience de la...
The discontinuation of services for the SeqOIA platform mechanically led to a 20% reduction in revenues in the first half of the year. Adjusted for this base effect, growth was 6% over the...
Hausse des prestations réalisées en 2023 par l’ensemble des plateformes de séquençage hors activités liées au COVID Excédent brut d’exploitation positif pour la troisième année consécutive...
Significant reduction of COVID-19 related activities Growth of all other lines of business Cash totaling €2.9m on Dec 31st, 2023 Laboratory in Évry accredited by the College of American...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.005 | -0.819672131148 | 0.61 | 0.61 | 0.555 | 3168 | 0.5946217 | DE |
4 | 0.085 | 16.3461538462 | 0.52 | 0.86 | 0.52 | 27507 | 0.70544484 | DE |
12 | 0.09 | 17.4757281553 | 0.515 | 0.86 | 0.436 | 14150 | 0.62900687 | DE |
26 | -0.02 | -3.2 | 0.625 | 0.86 | 0.436 | 8386 | 0.60956401 | DE |
52 | -0.171 | -22.0360824742 | 0.776 | 0.93 | 0.436 | 6818 | 0.65435767 | DE |
156 | -0.673 | -52.6604068858 | 1.278 | 1.57 | 0.436 | 4475 | 0.93464692 | DE |
260 | -0.685 | -53.1007751938 | 1.29 | 2.67 | 0.436 | 29233 | 1.74377443 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions